ASP Isotopes announces proposed merger of Noble Africa with ENDRA Life Sciences and $50 million private placement

Corporate Action

โดย GlobeNewswire·Read original

Summary · why it matters

ASP Isotopes announced that its wholly-owned subsidiary Noble Africa will merge with a subsidiary of ENDRA Life Sciences, with Noble Africa surviving and applying to list on Nasdaq under the ticker NOBA. The combined company will serve as a helium platform for Renergen’s Virginia Gas Project. A concurrent private placement is expected to generate approximately $50 million in gross proceeds, including about $20 million from ASP Isotopes as lead investor and roughly $30 million from other investors. Upon closing, ASP Isotopes is expected to own approximately 89% of the combined company, pre-closing ENDRA stockholders about 3%, and private placement investors other than ASPI about 7%. The transaction has been approved by both companies’ boards and is expected to close in the third or fourth quarter of 2026, subject to regulatory and stockholder approvals.

ASP Isotopes Inc. Common Stock ▲

ENDRA Life Sciences Inc ±

Impact on stocks 2

Energy Transition & Power Demand▲ · 1 stocks

ASP Isotopes Inc. Common Stock

▲ PositiveCapitalrelevance

ASP Isotopes leads $50M private placement and will own 89% of merged helium platform, providing capital and strategic control.

Biotech & Genomic Medicine▲ · 1 stocks

ENDRA Life Sciences Inc

± MixedCapitalrelevance

ENDRA Life Sciences subsidiary is being merged into Noble Africa; pre-closing ENDRA stockholders will own only ~3% of the combined entity.

Off-coverage companies 2

Noble Africa LLCPrivate▲ Positive

Capitalrelevance

Noble Africa will survive the merger and list on Nasdaq as NOBA, gaining access to public markets and $50M in funding.

Renergen LimitedPrivate▲ Positive

Demandrelevance

The merged company will serve as a helium platform for Renergen's Virginia Gas Project, securing a dedicated offtake and funding channel.